Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
Public ClinicalTrials.gov record NCT02432807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Masked, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Vancomycin Hydrochloride Ophthalmic Ointment 1.1% in Patients With Moderate to Severe Bacterial Conjunctivitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3 study to evaluate the safety and efficacy of a vancomycin hydrochloride ophthalmic ointment dosed 4 times daily for 7 days compared to placebo (vehicle) in patients with moderate to severed Gram-positive bacterial conjunctivitis.
Study identification
- NCT ID
- NCT02432807
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 303 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Year and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2015 (Actual)
- Primary completion
- May 31, 2018 (Actual)
- Completion
- May 31, 2018 (Actual)
- Last update posted
- Oct 23, 2024
2015 – 2018
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Paramount | California | — | — |
| Not listed | Petaluma | California | — | — |
| Not listed | Rancho Cordova | California | — | — |
| Not listed | Deerfield Beach | Florida | — | — |
| Not listed | Waterloo | Iowa | — | — |
| Not listed | Newton | Kansas | — | — |
| Not listed | Pittsburg | Kansas | — | — |
| Not listed | Shawnee Mission | Kansas | — | — |
| Not listed | Havre de Grace | Maryland | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Roseburg | Oregon | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Memphis | Tennessee | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02432807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02432807 live on ClinicalTrials.gov.